Role of nitric oxide in the pathogenesis of dengue

Dengue Bulletin

Volumn 31, Issue , 2007, Pages 118-123

  Añez, Germán ^a   Valero, Nereida ^a   Mosquera, Jess ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Dengue haemorrhagic fever; Dengue virus; Nitric oxide; Pathogenesis

Indexed keywords

NITRIC OXIDE;

ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; BLOOD LEVEL; DENGUE; DENGUE VIRUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; NITRIC OXIDE BLOOD LEVEL; NONHUMAN; PATHOGENESIS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VIRUS CELL INTERACTION;

DENGUE VIRUS;

EID: 56249147037     PISSN: 1020895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Añez G, Balza R, Valero N, Larreal Y. Economic impact of dengue and dengue hemorrhagic fever in the State of Zulia, Venezuela, 1997-2003. Rev Panam Salud Publica. 2006 May; 19(5): 314-20. Spanish.
2. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 2002 Feb; 10(2): 100-3.
3. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment and control. 2nd edn. Geneva: WHO; 1997.
4. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science. 1988 jan 29; 239(4839): 476-81.
5. Halstead SB. Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med. 1970 Apr; 42(5): 350-62.
6. Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol. 2006 Jan; 147 Suppl 1: S193-201.
7. Liaudet L, Soriano FG, Szabó C. Biology of nitric oxide signaling. Crit Care Med. 2000 Apr; 28(4 Suppl): N37-52.
8. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007 Jan; 87(1): 315-424.
9. Nagy G, Clark JM, Buzás EI, Gorman CL, Cope AP. Nitric oxide, chronic inflammation and autoimmunity. Immunol Lett. 2007 Jul 31; 111(1): 1-5.
10. Valero N, Espina LM, Añez G, Torres E, Mosquera JA. Short report: increased level of serum nitric oxide in patients with dengue. Am J Trop Med Hyg. 2002 Jun; 66(6): 762-4.
11. Chareonsirisuthigul T, Kalayanarooj S, Ubol S. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and proinflammatory cytokine production, in THP-1 cells. J Gen Virol. 2007 Feb; 88(Pt 2): 365-75.
12. Charnsilpa W, Takhampunya R, Endy TP, Mammen MP Jr, Libraty DH, Ubol S. Nitric oxide radical suppresses replication of wildtype dengue 2 viruses in vitro. J Med Virol. 2005 Sep; 77(1): 89-95.
13. Neves-Souza PC, Azeredo EL, Zagne SM, Valls-de-Souza R, Reis SR, Cerqueira DI, Nogueira RM, Kubelka CF. Inducible nitric oxide synthase (iNOS) expression in monocytes during acute dengue Fever in patients and during in vitro infection. BMC Infect Dis. 2005 Aug 18; 5:64.
14. Takhampunya R, Padmanabhan R, Ubol S. Antiviral action of nitric oxide on dengue virus type 2 replication. J Gen Virol. 2006 Oct; 87(Pt 10): 3003-11.
15. Marianneau P, Steffan AM, Royer C, Drouet MT, Jaeck D, Kim A, Deubel V. Infection of primary cultures of human Kupffer cells by dengue virus: no viral progeny synthesis, but cytokine production is evident. J Virol. 1999 Jun; 73(6): 5201-6.
16. Lin CF, Lei HY, Shiau AL, Liu HS, Yeh TM, Chen SH, Liu CC, Chiu SC, Lin YS. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J Immunol. 2002 Jul 15; 169(2):657-64.
17. Lin YS, Lin CF, Lei HY, Liu HS, Yeh TM, Chen SH, Liu CC. Antibody-mediated endothelial cell damage via nitric oxide. Curr Pharm Des. 2004; 10(2): 213-21.
18. Blackley S, Kou Z, Chen H, Quinn M, Rose RC, Schlesinger JJ, Coppage M, Jin X. Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J Viro.l 2007 Dec; 81(24): 13325-34.
19. Trairatvorakul P, Chongsrisawat V, Ngamvasinont D, Asawarachun D, Nantasook J, Poovorawan Y. Serum nitric oxide in children with dengue infection. Asian Pac J Allergy Immunol. 2005 Jun-Sep; 23(2-3): 115-9.
20. Halstead SB. Dengue in the Americas and Southeast Asia: do they differ? Rev Panam Salud Publica. 2006 Dec; 20(6): 407-15.
21. Ubol S, Chareonsirisuthigul T, Kasisith J, Klungthong C. Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells. Virology. 2008 Jul 5; 376(2): 290-6.
22. Keyaerts E, Vijgen L, Chen L, Maes P, Hedenstierna G, Van Ranst M. Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound. Int J Infect Dis. 2004 Jul; 8(4): 223-6.
23. Klingström J, Akerström S, Hardestam J, Stoltz M, Simon M, Falk KI, Mirazimi A, Rottenberg M, Lundkvist A. Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virions. Eur J Immunol. 2006 Oct; 36(10): 2649-57.
24. Lidbury BA, Mahalingam S. Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection. J Virol. 2000 Sep; 74(18): 8376-81.
25. Chesler DA, Dodard C, Lee GY, Levy DE, Reiss CS. Interferon-gamma-induced inhibition of neuronal vesicular stomatitis virus infection is STAT1 dependent. J Neurovirol. 2004 Feb; 10(1): 57-63.
26. Bi Z, Reiss CS. Inhibition of vesicular stomatitis virus infection by nitric oxide. J Virol. 1995 Apr; 69(4): 2208-13.
27. Simon M, Falk KI, Lundkvist A, Mirazimi A. Exogenous nitric oxide inhibits Crimean Congo hemorrhagic fever virus. Virus Res. 2006 Sep; 120(1-2): 184-90.
28. Saxena SK, Singh A, Mathur A. Antiviral effect of nitric oxide during Japanese encephalitis virus infection. Int J Exp Pathol. 2000 Apr; 81(2): 165-72.
29. Lin YL, Huang YL, Ma SH, Yeh CT, Chiou SY, Chen LK, Liao CL. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol. 1997 Jul; 71(7): 5227-35.
30. Espina LM, Valero NJ, Hernández JM, Mosquera JA. Increased apoptosis and expression of tumor necrosis factor-alpha caused by infection of cultured human monocytes with dengue virus. Am J Trop Med Hyg. 2003 Jan; 68(1): 48-53.
31. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol. 1998 Dec 1; 161(11): 6338-46.
32. Mosquera JA, Hernandez JP, Valero N, Espina LM, Añez GJ. Ultrastructural studies on dengue virus type 2 infection of cultured human monocytes. Virol J. 2005 Mar 31; 2: 26.
33. Jan JT, Chen BH, Ma SH, Liu CI, Tsai HP, Wu HC, Jiang SY, Yang KD, Shaio MF. Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: arachidonic acid, superoxide anion, and NF-kappaB are sequentially involved. J Virol. 2000 Sep; 74(18): 8680-91.
34. Myint KS, Endy TP, Mongkolsirichaikul D, Manomuth C, Kalayanarooj S, Vaughn DW, Nisalak A, Green S, Rothman AL, Ennis FA, Libraty DH. Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis. J Infect Dis. 2006 Sep 1; 194(5): 600-7.